NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: Custom Oligosaccharide Synthesis and Glycan Characterization at Creative Biolabs
Creative Biolabs offers integrated custom oligosaccharide synthesis and advanced glycan characterization services to support drug discovery, vaccine development, and biomarker research, helping researchers obtain structurally validated glycans for reliable downstream studies.
Creative Biolabs provides custom oligosaccharide synthesis of high-purity oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives, along with advanced glycan characterization using MS, HPLC, and NMR.
Oligosaccharides play critical roles in cell signaling, immune regulation, pathogen-host interactions, and disease progression, making them valuable tools for therapeutic, vaccine, and diagnostic research.
The structural complexity of oligosaccharides complicates synthesis, purification, and characterization. Creative Biolabs combines chemical, enzymatic, and chemoenzymatic synthesis with comprehensive analytical platforms to overcome these challenges.
Advanced glycan characterization is performed using mass spectrometry (MS), high-performance liquid chromatography (HPLC), and nuclear magnetic resonance (NMR) to determine structures, linkage patterns, sequences, and purity.
Creative Biolabs can synthesize custom oligosaccharides, complex glycans, tumor-associated carbohydrate antigens (TACAs), and functionalized carbohydrate derivatives.
By integrating custom synthesis with rigorous analytical characterization under one platform, researchers reduce technical risks, improve experimental reproducibility, and accelerate scientific discovery.
The services support structural biology, glycoprotein research, biomarker discovery, immunology, targeted drug delivery, and therapeutic development.
More information is available on Creative Biolabs' glycobiology platform at https://www.creative-biolabs.com/glycoprotein/.